GENE ONLINE|News &
Opinion
Blog

China
Funding Immunotherapy
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Partnerships AAV Gene Therapy
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
2022-11-08
China Immunotherapy
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
China WuXi Biologics
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
China Sanofi
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Trials & Approvals Kidney Disease
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
China Series B Funding
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
China Antibody Combination
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
China CDMO
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
China PD-1 Inhibitor
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
IPO China
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
China Breast Cancer
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
Trials & Approvals China
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
Funding Oncology
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
1 2 3 4 … 8
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top